Vietnam Blood-based Biomaker For Sports Medicine Market Size & Outlook
Vietnam blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Vietnam blood-based biomaker for sports medicine market highlights
- The Vietnam blood-based biomaker for sports medicine market generated a revenue of USD 2.8 million in 2023 and is expected to reach USD 3.4 million by 2030.
- The Vietnam market is expected to grow at a CAGR of 2.8% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 2.8 million |
| Market revenue in 2030 | USD 3.4 million |
| Growth rate | 2.8% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Vietnam accounted for 0.4% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 17.86% in 2023. Horizon Databook has segmented the Vietnam blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Vietnam has undergone a remarkable transformation, evolving from one of the world’s underdeveloped nations to a lower-middle-income country, with a GDP per capita of USD 4,086 in 2022. According to the International Monetary Fund World Economic Outlook, Vietnam’s GDP reached USD 406.45 billion in 2022, ranking it as the fifth-largest economy in Southeast Asia and 37th globally.
This economic rise is expected to drive significant improvements in the country’s healthcare infrastructure, including advancements in sports medicine. The growing focus on health & wellness, supported by increased investment, fosters the development of cutting-edge medical technologies like blood-based biomarkers.
Vietnam is significantly increasing its investment in sports, with budgets for elite sports reaching over USD 28 million in 2022 and surpassing USD 29 million in 2023. This rise in funding reflects the country’s commitment to developing its sports sector and enhancing the performance of its athletes on the international stage.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Vietnam blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Vietnam Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
